DIAN Informatics Core

$915,000UF1FY2014AGNIH

Washington University, Saint Louis MO

Investigators

Linked publications, trials & patents

Paper 37867465 Paper 37843849 Paper 37816643 Paper 37740921 Paper 37550416 Paper 37492802 Paper 37429916 Paper 37291760 Paper 37231491 Paper 37202169 Paper 37017737 Paper 37016671 Paper 36843330 Paper 36640138 Paper 36625756 Paper 36574316 Paper 36522155 Paper 36517172 Paper 36352225 Paper 35925685 Paper 35914670 Paper 35716696 Paper 35678403 Paper 35670654 Paper 35609137 Paper 35602652 Paper 35580594 Paper 35452806 Paper 35362200 Paper 35358703 Paper 35305339 Paper 35212149 Paper 35065037 Paper 34818016 Paper 34655980 Paper 34636637 Paper 34333107 Paper 34302786 Paper 34239130 Paper 34049986 Paper 33983116 Paper 33943045 Paper 33911285 Paper 33599811 Paper 33559218 Paper 33495373 Paper 33492294 Paper 33480178 Paper 33430685 Paper 33410601 Paper 33395982 Paper 33253432 Paper 33226734 Paper 33196147 Paper 33150749 Paper 32970522 Paper 32954344 Paper 32919611 Paper 32873693 Paper 32759192 Paper 32587883 Paper 32522711 Paper 32334404 Paper 32228870 Paper 32211499 Paper 32161412 Paper 32087291 Paper 32043733 Paper 32043719 Paper 32032730 Paper 31914221 Paper 31842726 Paper 31732016 Paper 31700988 Paper 31686371 Paper 31591557 Paper 31506247 Paper 31361916 Paper 30958365 Paper 30899092 Paper 30897203 Paper 30847382 Paper 30846386 Paper 30773445 Paper 30753379 Paper 30718410 Paper 30664784 Paper 30643031 Paper 30616208 Paper 30569014 Paper 30546007 Paper 30530186 Paper 30482868 Paper 30477568 Paper 30417072 Paper 30376508 Paper 30336198 Paper 30266303 Paper 30239611 Trial NCT00869817

Abstract

Autosomal dominant Alzheimer?s Disease (ADAD) represents a small fraction (<1%) of all Alzheimer?s Disease cases, but it presents a unique window into the disease. Because individuals possessing known ADADcausing mutations are destined to develop the disease at an early and relatively predictable age, they can be studied from an asymptomatic stage and the progression of the disease can be observed. The Dominantly Inherited Alzheimer?s Network (DIAN) will continue its study of ADAD in a systematic and comprehensive manner, acquiring biochemical, neuroimaging, cognitive, and clinical measures from individuals from families with known ADAD mutations. The Informatics Core will be responsible for managing all of the data acquired within DIAN, except for mutation status. A centralized database ? the Central Neuroimaging Data Archive (CNDA) ? will be deployed to store and make data available to investigators in a user-friendly manner. Data will be acquired at the performance sites and uploaded into the CNDA. Once uploaded, the data will reside in quarantine until passing several rounds of quality control checks to identify missing fields, outliers, and other discrepancies. Imaging data will be distributed to dedicated quality control sites for systematic post-processing and inspection. Once released from quarantine, the data will be made available to DIAN investigators via a data freeze produced and carefully orchestrated with the Biostatistics Core. Participant privacy and overall system security will be addressed with the utmost attention in all aspects of the Core?s infrastructure. The Informatics Core will maintain close interactions with each of the other cores. Regular reports will be prepared with the Biostatistics Core and presented to the Administration Core and Steering Committee. Support for the Imaging Core will include image upload/download tools, image file de-identification procedures, exchange with quality control sites, and implementation of automated processing and analysis workflows. All of these procedures and systems currently are in place in DIAN and function smoothly.

View original record on NIH RePORTER →